Literature DB >> 7523403

Interleukin-6 signaling via four transcription factors binding palindromic enhancers of different genes.

S Harroch1, M Revel, J Chebath.   

Abstract

Interferons (IFNs), as well as some interleukins, growth factors, and hormones, all induce tyrosine phosphorylation of STAT1 and additional transcription factors of similar sizes. These factors are activated to translocate to nucleus and bind to enhancers of consensus sequence TTnCnnnAA (gamma-IFN activated sequence-like enhancers). In mammary cells or hybridoma B9 cells, four distinct tyrosine-phosphorylated transcription complexes activated by interleukin-6 (IL-6) and IFN-beta were observed: pIRFA and complexes I, II, and III (of increasing electrophoretic mobility). The factors have unequal affinities for enhancers of different genes; they are activated with distinct kinetics and to different extents by IL-6 and IFNs. The pIRFA band isolated from IL-6-stimulated B9 hybridoma cells revealed three DNA-interacting components: two large subunits of 91 and 98 kDa, as well as a small component of 46 kDa not seen in other complexes analyzed. One of the large pIRFA subunits may be APRF/STAT3, since pIRFA reacted with anti-APRF antibodies as do complexes I and II. However, pIRFA did not react with antibodies to STAT1, indicating STAT1 is not the other large component of pIRFA. Complex II, which reacted to anti-acute phase response factor antibodies also reacted to anti-STAT1 antibodies, whereas complex III reacted only to anti-STAT1 and was the only complex resistant to N-ethylmaleimide. By its multimeric subunit structure and its cytokine and enhancer sequence specificities, the slowly migrating pIRFA band appears as a novel tyrosine-phosphorylated transcription complex acting on a subset of gamma-IFN activated sequence-like enhancers.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7523403

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  A central role for Stat3 in IL-6-induced regulation of growth and differentiation in M1 leukemia cells.

Authors:  K Nakajima; Y Yamanaka; K Nakae; H Kojima; M Ichiba; N Kiuchi; T Kitaoka; T Fukada; M Hibi; T Hirano
Journal:  EMBO J       Date:  1996-07-15       Impact factor: 11.598

2.  A protein-arginine methyltransferase binds to the intracytoplasmic domain of the IFNAR1 chain in the type I interferon receptor.

Authors:  C Abramovich; B Yakobson; J Chebath; M Revel
Journal:  EMBO J       Date:  1997-01-15       Impact factor: 11.598

3.  Activation of different Stat5 isoforms contributes to cell-type-restricted signaling in response to interferons.

Authors:  A Meinke; F Barahmand-Pour; S Wöhrl; D Stoiber; T Decker
Journal:  Mol Cell Biol       Date:  1996-12       Impact factor: 4.272

4.  Interleukin-6-specific activation of the C/EBPdelta gene in hepatocytes is mediated by Stat3 and Sp1.

Authors:  C A Cantwell; E Sterneck; P F Johnson
Journal:  Mol Cell Biol       Date:  1998-04       Impact factor: 4.272

5.  STAT protein complexes activated by interferon-gamma and gp130 signaling molecules differ in their sequence preferences and transcriptional induction properties.

Authors:  P Lamb; H M Seidel; J Haslam; L Milocco; L V Kessler; R B Stein; J Rosen
Journal:  Nucleic Acids Res       Date:  1995-08-25       Impact factor: 16.971

6.  Activation-induced inhibition of interleukin 6-mediated T cell survival and signal transducer and activator of transcription 1 signaling.

Authors:  T K Teague; B C Schaefer; D Hildeman; J Bender; T Mitchell; J W Kappler; P Marrack
Journal:  J Exp Med       Date:  2000-03-20       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.